Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
出版年份 2019 全文链接
标题
Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
作者
关键词
-
出版物
Brain and Behavior
Volume -, Issue -, Pages e01312
出版商
Wiley
发表日期
2019-05-07
DOI
10.1002/brb3.1312
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
- (2019) Alex Molassiotis et al. BMC CANCER
- Associations Between Perceived Stress and Chemotherapy-Induced Peripheral Neuropathy and Otoxicity in Adult Cancer Survivors
- (2018) Christine Miaskowski et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Chemotherapy-Induced Neuropathy in Cancer Survivors
- (2017) Christine Miaskowski et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30
- (2017) Hanna Bandos et al. JNCI-Journal of the National Cancer Institute
- The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice
- (2017) Natalie B. Simon et al. QUALITY OF LIFE RESEARCH
- Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey
- (2017) J . Matt McCrary et al. SUPPORTIVE CARE IN CANCER
- Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30
- (2017) Hanna Bandos et al. JNCI-Journal of the National Cancer Institute
- Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk
- (2016) Ting Bao et al. BREAST CANCER RESEARCH AND TREATMENT
- Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials
- (2016) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study
- (2016) Heather Greenlee et al. JNCI-Journal of the National Cancer Institute
- Diabetes and Body Mass Index Are Associated with Neuropathy and Prognosis in Colon Cancer Patients Treated with Capecitabine and Oxaliplatin Adjuvant Chemotherapy
- (2016) Alessandro Ottaiano et al. ONCOLOGY
- BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study
- (2016) Heather Greenlee et al. JNCI-Journal of the National Cancer Institute
- Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors
- (2015) L. Eckhoff et al. EUROPEAN JOURNAL OF CANCER
- Neuropathic Symptoms and Their Risk Factors in Medical Oncology Outpatients With Colorectal vs. Breast, Lung, or Prostate Cancer: Results From a Prospective Multicenter Study
- (2015) Mark A. Lewis et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Chemotherapy-induced peripheral neuropathy after neoadjuvant or adjuvant treatment of breast cancer: a prospective cohort study
- (2015) Susana Pereira et al. SUPPORTIVE CARE IN CANCER
- Mechanisms of chemotherapy-induced behavioral toxicities
- (2015) Elisabeth G. Vichaya et al. Frontiers in Neuroscience
- Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: Results from the population-based PROFILES registry
- (2014) Nicole P.M. Ezendam et al. GYNECOLOGIC ONCOLOGY
- Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
- (2014) Marta Seretny et al. PAIN
- Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review
- (2014) Floortje Mols et al. SUPPORTIVE CARE IN CANCER
- Should we adjust for a confounder if empirical and theoretical criteria yield contradictory results? A simulation study
- (2014) Paul H. Lee Scientific Reports
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
- (2012) G. Cavaletti et al. ANNALS OF ONCOLOGY
- Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation
- (2012) Karima Osmani et al. JOURNAL OF NEUROLOGY
- Factors Exacerbating Peripheral Neuropathy Induced by Paclitaxel Plus Carboplatin in Non-small Cell Lung Cancer
- (2012) Kazuyoshi Kawakami et al. ONCOLOGY RESEARCH
- Therapy of chemotherapy-induced peripheral neuropathy
- (2009) Thomas J. Kaley et al. BRITISH JOURNAL OF HAEMATOLOGY
- Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer
- (2008) C. Wan et al. ANNALS OF ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started